These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1690477)

  • 1. Effects of prazosin HCl on micturition disturbance associated with benign prostatic hypertrophy and bladder neck contracture.
    Kohama Y; Watanabe H; Sen Y; Yamamoto Y; Morioka M; Fujita Y
    Urol Int; 1990; 45 Suppl 1():26-9. PubMed ID: 1690477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an alpha 1-adrenergic blocker (prazosin HCl) on micturition disturbances associated with benign prostatic hypertrophy.
    Shimizu K; Nakai K; Imai K; Yamanaka H
    Urol Int; 1990; 45 Suppl 1():36-9. PubMed ID: 1690479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of prazosin HCl in the treatment of urinary flow obstruction due to prostatic hypertrophy.
    Kondo A; Gotoh M; Saito M; Takita T; Kobayashi M; Otani T; Ito K
    Urol Int; 1990; 45 Suppl 1():4-17. PubMed ID: 1690480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies on the effectiveness of prazosin HCl (Minipress tablets) in the treatment of dysuria accompanying benign prostatic hyperplasia.
    Aoki H; Ohninata M; Tsuzuki T; Ohhori M; Shiraiwa Y; Yamaguchi O; Kobayashi M; Yokota T; Numazato S; Sakuma S
    Urol Int; 1990; 45 Suppl 1():18-25. PubMed ID: 1690476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prazosin HCl on the urethral pressure profile in patients with benign prostatic hyperplasia.
    Nakamura K; Kawashita E; Osumi Y; Usui T; Ishibe T
    Urol Int; 1990; 45 Suppl 1():30-5. PubMed ID: 1690478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study.
    Yamaguchi O; Shiraiwa Y; Kobayashi M; Yokota T; Ohinata M; Aoki H; Tsuzuki T; Ohori M
    Urol Int; 1990; 45 Suppl 1():40-6. PubMed ID: 1690481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction.
    Chapple CR; Christmas TJ; Milroy EJ
    Urol Int; 1990; 45 Suppl 1():47-55. PubMed ID: 1690482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and side-effects of prazosin as a symptomatic treatment of benign prostatic obstruction.
    Ruutu ML; Hansson E; Juusela HE; Permi JE; Rusk JI; Sotarauta MT; Talja MT; Wuokko EJ; Mattila MJ
    Scand J Urol Nephrol; 1991; 25(1):15-9. PubMed ID: 1710823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy.
    Le Duc A; Cariou G; Baron C; Cukier J; Quentel P; Faure G; Rambeaud JJ; Navratil H; Costa P; Richaud JJ
    Urol Int; 1990; 45 Suppl 1():56-62. PubMed ID: 1690483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker].
    Katsumi T; Murayama K
    Hinyokika Kiyo; 1992 Sep; 38(9):1089-92. PubMed ID: 1384297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic effectiveness and safety of prazosin in the symptomatic treatment of benign prostatic hypertrophy].
    Jiménez Cruz JF; Server Pastor G; Rioja Sanz C; Salinas Casado J; Vela Navarrete R; Virseda Chamorro M
    Actas Urol Esp; 1990; 14(1):31-5. PubMed ID: 1692659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy].
    Park YC; Nishioka T; Arai Y; Tomoyoshi T; Kurita T; Hayashida H; Nagai N; Inoue H; Kataoka K; Kitagawa Y
    Hinyokika Kiyo; 1992 Jul; 38(7):857-68. PubMed ID: 1381869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prazosin in men with symptoms of bladder neck obstruction and a non-hyperplastic prostate.
    Hedlund H; Andersson KE
    Scand J Urol Nephrol; 1989; 23(4):251-4. PubMed ID: 2480639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia.
    Witjes WP; Rosier FW; de Wildt MJ; van Iersel MP; Debruyne FM; de La Rosette JJ
    J Urol; 1996 Apr; 155(4):1317-23. PubMed ID: 8632523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-week placebo-controlled double-blind study of prazosin in the treatment of prostatic obstruction due to benign prostatic hyperplasia.
    Chapple CR; Stott M; Abrams PH; Christmas TJ; Milroy EJ
    Br J Urol; 1992 Sep; 70(3):285-94. PubMed ID: 1384919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study.
    Kirby RS; Coppinger SW; Corcoran MO; Chapple CR; Flannigan M; Milroy EJ
    Br J Urol; 1987 Aug; 60(2):136-42. PubMed ID: 2444306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of naftopidil on urethral obstruction in benign prostatic hyperplasia: assessment by urodynamic studies.
    Yasuda K; Yamanishi T; Tojo M; Nagashima K; Akimoto S; Shimazaki J
    Prostate; 1994 Jul; 25(1):46-52. PubMed ID: 7517541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.